{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T22:52:08Z","timestamp":1773010328738,"version":"3.50.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,2,20]],"date-time":"2024-02-20T00:00:00Z","timestamp":1708387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,2,20]],"date-time":"2024-02-20T00:00:00Z","timestamp":1708387200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Anesthesiol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Esketamine is increasingly used in clinical anesthesia. The effect of esketamine on the blood flow velocity of the middle cerebral artery has a clinical guiding effect. To investigate the effect of esketamine combined with propofol-induced general anesthesia for endotracheal intubation on the blood flow velocity of middle cerebral artery and hemodynamics during the induction period.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The randomized clinical trial included 80 patients aged 20-65 years who would undergo non-intracranial elective surgery under general anesthesia in our hospital from May 2022 to May 2023. The participants were divided into two groups based on anesthesia drugs: sufentanil 0.5\u03bcg\/kg (group C) or 1.5mg\/kg esketamine (group E). The primary outcome was variation value in average cerebral blood velocity. The secondary outcomes included cerebral blood flow velocities (CBFV), blood pressure (BP) and heart rate (HR) at four different time points: before induction of general anesthesia (T<jats:sub>0<\/jats:sub>), 1 min after the induction drug injected (T<jats:sub>1<\/jats:sub>), before endotracheal intubation (T<jats:sub>2<\/jats:sub>), and 1min after endotracheal intubation (T<jats:sub>3<\/jats:sub>). The occurrence of hypotension, hypertension, tearing and choking during induction was also documented.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The variation of average CBFV from time T<jats:sub>0<\/jats:sub> to T<jats:sub>2<\/jats:sub>(\u0394V<jats:sub>m1<\/jats:sub>) and the variation from time T<jats:sub>3<\/jats:sub> to T<jats:sub>0<\/jats:sub> (\u0394V<jats:sub>m2<\/jats:sub>) were not obviously different. The median consumption of intraoperative sufentanil in group C was obviously lower than that in group E. At T<jats:sub>1<\/jats:sub>, the mean HR of group E was significantly higher than that of group C. At T<jats:sub>2<\/jats:sub> and T<jats:sub>3<\/jats:sub>, the BP and HR of group E were obviously higher than that of group C. At T<jats:sub>2<\/jats:sub>, the CBFV in the group E were obviously higher than those in the group C. The incidence of hypotension was significantly reduced in the group E compared with the group C. There were no differences in the other outcomes.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The induction of esketamine combined with propofol does not increase the blood flow velocity of middle cerebral artery. Esketamine is advantageous in maintaining hemodynamic stability during induction. Furthermore, the administration of esketamine did not result in an increased incidence of adverse effects.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial Registration<\/jats:title>\n                <jats:p>15\/06\/2023 clinicaltrials.gov ChiCTR2300072518 <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.chictr.org.cn\/bin\/project\/edit?pid=176675\">https:\/\/www.chictr.org.cn\/bin\/project\/edit?pid=176675<\/jats:ext-link>.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12871-024-02446-4","type":"journal-article","created":{"date-parts":[[2024,2,20]],"date-time":"2024-02-20T07:02:40Z","timestamp":1708412560000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["The effect of esketamine combined with propofol-induced general anesthesia on cerebral blood flow velocity: a randomized clinical trial"],"prefix":"10.1186","volume":"24","author":[{"given":"Shuang","family":"Yan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiying","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaihua","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,2,20]]},"reference":[{"issue":"10","key":"2446_CR1","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1007\/s00228-022-03374-3","volume":"78","author":"L La Via","year":"2022","unstructured":"La Via L, Sanfilippo F, Cuttone G, Dezio V, Falcone M, Brancati S, Crimi C, Astuto M. Use of ketamine in patients with refractory severe asthma exacerbations: systematic review of prospective studies. Eur J Clin Pharmacol. 2022;78(10):1613\u201322.","journal-title":"Eur J Clin Pharmacol."},{"issue":"3","key":"2446_CR2","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1176\/appi.ajp.2014.13101434","volume":"171","author":"AF Schatzberg","year":"2014","unstructured":"Schatzberg AF. A word to the wise about ketamine. Am J Psychiatry. 2014;171(3):262\u20134.","journal-title":"Am J Psychiatry."},{"issue":"3","key":"2446_CR3","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1111\/j.1365-2044.1995.tb04561.x","volume":"50","author":"S Strebel","year":"1995","unstructured":"Strebel S, Kaufmann M, Schaefer HG. Effects of ketamine on cerebral blood flow velocity in humans. Influence of pretreatment with midazolam or esmolo. Anaesthesia. 1995;50(3):223\u20138.","journal-title":"Anaesthesia"},{"issue":"1","key":"2446_CR4","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s12028-020-00975-7","volume":"33","author":"M Gregers","year":"2020","unstructured":"Gregers M, Mikkelsen S, Lindvig KP, Brochner AC. Ketamine as an anesthetic for patients with acute brain injury: a systematic review. Neurocrit Care. 2020;33(1):273\u201382.","journal-title":"Neurocrit Care."},{"key":"2446_CR5","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.jad.2020.03.040","volume":"269","author":"Y Tan","year":"2020","unstructured":"Tan Y, Hashimoto K. Risk of psychosis after repeated intermittent administration of (s)-ketamine, but not (r)-ketamine, in mice. J Affect Disord. 2020;269:198\u2013200.","journal-title":"J Affect Disord."},{"issue":"2","key":"2446_CR6","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1213\/00000539-200002000-00026","volume":"90","author":"K Sakai","year":"2000","unstructured":"Sakai K, Cho S, Fukusaki M, Shibata O, Sumikawa K. The effects of propofol with and without ketamine on human cerebral blood flow velocity and CO2 response. Anesth Analg. 2000;90(2):377\u201382.","journal-title":"Anesth Analg."},{"issue":"2","key":"2446_CR7","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1111\/fcp.12508","volume":"34","author":"Y Lu","year":"2020","unstructured":"Lu Y, Ding X, Wu X, Huang S. Ketamine inhibits lps-mediated bv2 microglial inflammation via NMDA receptor blockage. Fundam Clin Pharmacol. 2020;34(2):229\u201337.","journal-title":"Fundam Clin Pharmacol."},{"issue":"7","key":"2446_CR8","doi-asserted-by":"publisher","first-page":"3449","DOI":"10.1111\/jcmm.16426","volume":"25","author":"L Wang","year":"2021","unstructured":"Wang L, Deng B, Yan P, Wu H, Li C, Zhu H, Du J, Hou L. Neuroprotective effect of ketamine against TNF-alpha-induced necroptosis in hippocampal neurons. J Cell Mol Med. 2021;25(7):3449\u201359.","journal-title":"J Cell Mol Med."},{"issue":"2","key":"2446_CR9","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1097\/00000542-200508000-00008","volume":"103","author":"JW Langsjo","year":"2005","unstructured":"Langsjo JW, Maksimow A, Salmi E, Kaisti K, Aalto S, Oikonen V, Hinkka S, Aantaa R, Sipila H, Viljanen T, Parkkola R, Scheinin H. S-ketamine anesthesia increases cerebral blood flow in excess of the metabolic needs in humans. Anesthesiology. 2005;103(2):258\u201368.","journal-title":"Anesthesiology."},{"issue":"10","key":"2446_CR10","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1097\/EJA.0000000000000639","volume":"34","author":"M Poterman","year":"2017","unstructured":"Poterman M, Scheeren T, van der Velde MI, Buisman PL, Allaert S, Struys M, Kalmar AF. Prophylactic atropine administration attenuates the negative haemodynamic effects of induction of anaesthesia with propofol and high-dose remifentanil: a randomised controlled trial. Eur J Anaesthesiol. 2017;34(10):695\u2013701.","journal-title":"Eur J Anaesthesiol."},{"issue":"2","key":"2446_CR11","doi-asserted-by":"publisher","first-page":"116","DOI":"10.2174\/1567201816666190313160438","volume":"14","author":"K Sridharan","year":"2019","unstructured":"Sridharan K, Sivaramakrishnan G. Comparison of fentanyl, remifentanil, sufentanil and alfentanil in combination with propofol for general anesthesia: a systematic review and meta-analysis of randomized controlled trials. Curr Clin Pharmacol. 2019;14(2):116\u201324.","journal-title":"Curr Clin Pharmacol."},{"issue":"2","key":"2446_CR12","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1177\/096721099300100204","volume":"1","author":"A Usui","year":"1993","unstructured":"Usui A, Hotta T, Hiroura M, Murase M, Maeda M, Koyama T, Tanaka M, Takeuchi E, Abe T. Cerebral metabolism and function during normothermic retrograde cerebral perfusion. Cardiovasc Surg. 1993;1(2):107\u201312.","journal-title":"Cardiovasc Surg."},{"issue":"1","key":"2446_CR13","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1161\/01.STR.20.1.45","volume":"20","author":"R Aaslid","year":"1989","unstructured":"Aaslid R, Lindegaard KF, Sorteberg W, Nornes H. Cerebral autoregulation dynamics in humans. Stroke. 1989;20(1):45\u201352.","journal-title":"Stroke."},{"issue":"1\u20132","key":"2446_CR14","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/BF01577739","volume":"97","author":"W Sorteberg","year":"1989","unstructured":"Sorteberg W, Lindegaard KF, Rootwelt K, Dahl A, Russell D, Nyberg-Hansen R, Nornes H. Blood velocity and regional blood flow in defined cerebral artery systems. Acta Neurochir (Wien). 1989;97(1\u20132):47\u201352.","journal-title":"Acta Neurochir (Wien)."},{"issue":"4","key":"2446_CR15","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1093\/bja\/aev215","volume":"115","author":"TT Dong","year":"2015","unstructured":"Dong TT, Mellin-Olsen J, Gelb AW. Ketamine: a growing global health-care need. Br J Anaesth. 2015;115(4):491\u20133.","journal-title":"Br J Anaesth."},{"issue":"11","key":"2446_CR16","doi-asserted-by":"publisher","first-page":"6704","DOI":"10.1038\/s41380-021-01093-2","volume":"26","author":"J Bonaventura","year":"2021","unstructured":"Bonaventura J, Lam S, Carlton M, Boehm MA, Gomez JL, Solis O, Sanchez-Soto M, Morris PJ, Fredriksson I, Thomas CJ, Sibley DR, Shaham Y, Zarate CA Jr, Michaelides M. Pharmacological and behavioral divergence of ketamine enantiomers: implications for abuse liability. Mol Psychiatry. 2021;26(11):6704\u201322.","journal-title":"Mol Psychiatry."},{"issue":"1","key":"2446_CR17","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1097\/ALN.0b013e31823d010a","volume":"116","author":"M Eikermann","year":"2012","unstructured":"Eikermann M, Grosse-Sundrup M, Zaremba S, Henry ME, Bittner EA, Hoffmann U, Chamberlin NL. Ketamine activates breathing and abolishes the coupling between loss of consciousness and upper airway dilator muscle dysfunction. Anesthesiology. 2012;116(1):35\u201346.","journal-title":"Anesthesiology."},{"issue":"3","key":"2446_CR18","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1097\/00000542-200309000-00016","volume":"99","author":"JW Langsjo","year":"2003","unstructured":"Langsjo JW, Kaisti KK, Aalto S, Hinkka S, Aantaa R, Oikonen V, Sipila H, Kurki T, Silvanto M, Scheinin H. Effects of subanesthetic doses of ketamine on regional cerebral blood flow, oxygen consumption, and blood volume in humans. Anesthesiology. 2003;99(3):614\u201323.","journal-title":"Anesthesiology."},{"issue":"5","key":"2446_CR19","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1097\/00000542-200405000-00006","volume":"100","author":"JW Langsjo","year":"2004","unstructured":"Langsjo JW, Salmi E, Kaisti KK, Aalto S, Hinkka S, Aantaa R, Oikonen V, Viljanen T, Kurki T, Silvanto M, Scheinin H. Effects of subanesthetic ketamine on regional cerebral glucose metabolism in humans. Anesthesiology. 2004;100(5):1065\u201371.","journal-title":"Anesthesiology."},{"issue":"2","key":"2446_CR20","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1111\/j.1399-6576.2011.02561.x","volume":"56","author":"L Schlunzen","year":"2012","unstructured":"Schlunzen L, Juul N, Hansen KV, Cold GE. Regional cerebral blood flow and glucose metabolism during propofol anaesthesia in healthy subjects studied with positron emission tomography. Acta Anaesthesiol Scand. 2012;56(2):248\u201355.","journal-title":"Acta Anaesthesiol Scand."},{"issue":"2","key":"2446_CR21","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1097\/ANA.0000000000000234","volume":"28","author":"FA Zeiler","year":"2016","unstructured":"Zeiler FA, Sader N, Gillman LM, Teitelbaum J, West M, Kazina CJ. The cerebrovascular response to ketamine: a systematic review of the animal and human literature. J Neurosurg Anesthesiol. 2016;28(2):123\u201340.","journal-title":"J Neurosurg Anesthesiol."},{"issue":"6","key":"2446_CR22","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1111\/cns.12072","volume":"19","author":"S Marland","year":"2013","unstructured":"Marland S, Ellerton J, Andolfatto G, Strapazzon G, Thomassen O, Brandner B, Weatherall A, Paal P. Ketamine: use in anesthesia. Cns Neurosci Ther. 2013;19(6):381\u20139.","journal-title":"Cns Neurosci Ther."},{"issue":"5","key":"2446_CR23","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1007\/s40263-018-0519-3","volume":"32","author":"P Molero","year":"2018","unstructured":"Molero P, Ramos-Quiroga JA, Martin-Santos R, Calvo-Sanchez E, Gutierrez-Rojas L, Meana JJ. Antidepressant efficacy and tolerability of ketamine and esketamine: a critical review. Cns Drugs. 2018;32(5):411\u201320.","journal-title":"Cns Drugs."},{"issue":"5","key":"2446_CR24","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1093\/bja\/77.5.625","volume":"77","author":"L Arendt-Nielsen","year":"1996","unstructured":"Arendt-Nielsen L, Nielsen J, Petersen-Felix S, Schnider TW, Zbinden AM. Effect of racemic mixture and the (s+)-isomer of ketamine on temporal and spatial summation of pain. Br J Anaesth. 1996;77(5):625\u201331.","journal-title":"Br J Anaesth."},{"issue":"3","key":"2446_CR25","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1097\/00000542-200309000-00015","volume":"99","author":"KK Kaisti","year":"2003","unstructured":"Kaisti KK, Langsjo JW, Aalto S, Oikonen V, Sipila H, Teras M, Hinkka S, Metsahonkala L, Scheinin H. Effects of sevoflurane, propofol, and adjunct nitrous oxide on regional cerebral blood flow, oxygen consumption, and blood volume in humans. Anesthesiology. 2003;99(3):603\u201313.","journal-title":"Anesthesiology."},{"key":"2446_CR26","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.neuroimage.2016.12.080","volume":"148","author":"M Qiu","year":"2017","unstructured":"Qiu M, Scheinost D, Ramani R, Constable RT. Multi-modal analysis of functional connectivity and cerebral blood flow reveals shared and unique effects of propofol in large-scale brain networks. Neuroimage. 2017;148:130\u201340.","journal-title":"Neuroimage."},{"issue":"1","key":"2446_CR27","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.bja.2018.04.008","volume":"121","author":"L Laaksonen","year":"2018","unstructured":"Laaksonen L, Kallioinen M, Langsjo J, Laitio T, Scheinin A, Scheinin J, Kaisti K, Maksimow A, Kallionpaa RE, Rajala V, Johansson J, Kantonen O, Nyman M, Siren S, Valli K, Revonsuo A, Solin O, Vahlberg T, Alkire M, Scheinin H. Comparative effects of dexmedetomidine, propofol, sevoflurane, and s-ketamine on regional cerebral glucose metabolism in humans: a positron emission tomography study. Br J Anaesth. 2018;121(1):281\u201390.","journal-title":"Br J Anaesth."},{"key":"2446_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2022.106312","volume":"179","author":"N Zhou","year":"2022","unstructured":"Zhou N, Liang X, Gong J, Li H, Liu W, Zhou S, Xiang W, Li Z, Huang Y, Mo X, Li W. S-ketamine used during anesthesia induction increases the perfusion index and mean arterial pressure after induction: a randomized, double-blind, placebo-controlled trial. Eur J Pharm Sci. 2022;179: 106312.","journal-title":"Eur J Pharm Sci."},{"issue":"6","key":"2446_CR29","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1111\/jcpt.13604","volume":"47","author":"J Li","year":"2022","unstructured":"Li J, Wang Z, Wang A, Wang Z. Clinical effects of low-dose esketamine for anaesthesia induction in the elderly: a randomized controlled trial. J Clin Pharm Ther. 2022;47(6):759\u201366.","journal-title":"J Clin Pharm Ther."}],"container-title":["BMC Anesthesiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12871-024-02446-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12871-024-02446-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12871-024-02446-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,20]],"date-time":"2024-02-20T07:03:32Z","timestamp":1708412612000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcanesthesiol.biomedcentral.com\/articles\/10.1186\/s12871-024-02446-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,20]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["2446"],"URL":"https:\/\/doi.org\/10.1186\/s12871-024-02446-4","relation":{},"ISSN":["1471-2253"],"issn-type":[{"value":"1471-2253","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,20]]},"assertion":[{"value":"25 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki and approved by the ethics committee of The First Affiliated Hospital of Chongqing Medical University (NO:2020-072, 23\/03\/2022), written informed consent was obtained from all subjects.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"66"}}